Life sciences is one of the few industries where AI is reshaping both the science and the operations simultaneously. AlphaFold has compressed years of crystallography into seconds. Generative models propose molecular candidates that conventional screening would never surface. But the impact extends beyond discovery. Pharmaceutical manufacturing still runs on fixed-parameter batch processes, where small deviations compound into yield losses. We work with peptide manufacturers where even small improvements in yield have direct commercial consequence, and we have experience navigating GxP compliance and the auditability requirements that come with deploying AI into regulated operations.
ML models trained on historical batch data to predict and prevent yield-limiting deviations in real time. We work with peptide manufacturers where even small improvements in yield have direct commercial consequence. Life sciences consulting that starts at the process, not the strategy deck.
AI drug discovery is accelerating every stage of the pipeline. Generative models propose molecular candidates that conventional screening would never surface. Generative AI in life sciences is moving from research papers to production pipelines, and the organisations that deploy it first will compound the advantage.
Data infrastructure connecting laboratory instruments, ELN systems, and analytical platforms to ML-ready datasets. Automated feature extraction, cleaning, and versioning. The digital transformation pharma R&D needs to move from manual experiment tracking to reproducible, machine-readable workflows.
AI consulting for biotech and pharmaceutical organisations. We scope, build, and deploy ML systems across the development and manufacturing lifecycle. We have experience navigating GxP requirements and working within the regulatory constraints that define this industry.
Tell us about your challenge. We’ll tell you how AI can solve it.
Start a conversation→